APA (7th ed.) Citation

Kröger, N., Iacobelli, S., Franke, G., Platzbecker, U., Uddin, R., Hübel, K., . . . Witte, T. d. (2017). Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: A prospective randomized phase III study of the EBMT (RICMAC Trial). Journal of clinical oncology, 35(19), . https://doi.org/10.1200/JCO.2016.70.7349

Chicago Style (17th ed.) Citation

Kröger, Nicolaus, et al. "Dose-reduced Versus Standard Conditioning Followed by Allogeneic Stem-cell Transplantation for Patients with Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)." Journal of Clinical Oncology 35, no. 19 (2017). https://doi.org/10.1200/JCO.2016.70.7349.

MLA (9th ed.) Citation

Kröger, Nicolaus, et al. "Dose-reduced Versus Standard Conditioning Followed by Allogeneic Stem-cell Transplantation for Patients with Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)." Journal of Clinical Oncology, vol. 35, no. 19, 2017, https://doi.org/10.1200/JCO.2016.70.7349.